Palomino Laboratories Inc. - 10-Q Filing
Palomino Laboratories Inc. reports Q3 2026 results with focus on R&D, G&A expenses, and equity incentive plan updates.
Tickers: $PALX
Read the full article at SEC EDGAR
Part of the story Palomino Laboratories Inc. - 10-Q Filing (2 articles)